Featured Research

from universities, journals, and other organizations

Scientists At The Scripps Research Institute Discover A Therapeutic Strategy For "Misfolding Diseases" Analogous To Alzheimer's Disease

Date:
October 4, 2001
Source:
Scripps Research Institute
Summary:
Professor Jeffery W. Kelly, Ph.D., and his colleagues in the Department of Chemistry and The Skaggs Institute for Chemical Biology at The Scripps Research Institute (TSRI) have uncovered a potentially useful strategy to treat the rare disease familial amyloid polyneuropathy (FAP) -- an approach that may be generally useful for intervention in other amyloid diseases.

La Jolla, CA, September 28, 2001 -- Professor Jeffery W. Kelly, Ph.D., and his colleagues in the Department of Chemistry and The Skaggs Institute for Chemical Biology at The Scripps Research Institute (TSRI) have uncovered a potentially useful strategy to treat the rare disease familial amyloid polyneuropathy (FAP) -- an approach that may be generally useful for intervention in other amyloid diseases.

Related Articles


In the current issue of the journal Science, the team demonstrates that it is possible to prevent the protein shape changes that cause FAP, a disease that is analogous to Alzheimer's. The strategy is to introduce another protein that interacts with the protein capable of aberrant shape changes, preventing them.

"I'm very excited about pursuing these potential therapeutic opportunities," says Kelly.

Amyloid-forming diseases like FAP are generally characterized by the formation of microscopic fibrils made up of hundreds of misfolded proteins that cluster together and deposit in organs, interfering with their normal function.

FAP, a rare amyloid disease, is caused by the misfolding of the protein transthyretin (TTR), which is secreted by the liver into the bloodstream to carry thyroid hormone and vitamin A. Normally, TTR circulates in the blood as an active "tetramer" made up of four separate copies, or protein subunits, that bind to each other.

These subunits come from two different genes on two different chromosomes. The resulting tetramers are composed of identical protein subunits when the genes are identical.

However, when one of the copies has a heritable defect, hybrid tetramers form that are composed of mutant and normal subunits. The inclusion of mutated subunits makes the tetramer less stable and causes the four subunits to dissociate under conditions where they are not supposed to. Once the subunits are free, they can misfold and reassemble into the hair-like amyloid fibrils.

These fibrils cause the disease FAP by building up around peripheral nerve and muscle tissue, disrupting their function and leading to numbness and muscle weakness, and -- in advanced cases -- failure of the gastrointestinal tract. The current treatment for FAP is a liver transplant, which replaces the mutant gene with a normal copy.

Kelly and his colleagues discovered that a "suppressor" TTR subunit incorporated into a TTR tetramer with disease-associated destabilizing subunits prevents the tetramer from dissociating into potential fibril-forming monomers. Significantly, they found that incorporating even one of the suppressor subunit into a tetramer where the remainder of the subunits have disease-associated mutations doubles its stability. "The suppressor protein subunits prevent misfolding by preventing dissociation," says Kelly.

This "trans" suppression approach may form the basis for a new therapy for FAP, in which a patient could receive an injection of the suppressor protein. The idea may also work with other diseases where the protein normally engages in protein–protein interactions. When gene therapy becomes practical, one may be able to introduce the suppressor gene directly into the organ that makes the aberrant protein. The protective subunit will therefore be incorporated during biosynthesis, thus preventing later misfolding.

The research article, "Trans-Suppression of Misfolding in an Amyloid Disease" is authored by Per Hammarstrom, Frank Schneider, and Jeffery W. Kelly and appears in the September 28, 2001 issue of the journal Science.

The research was funded in part by the National Institutes of Health, The Skaggs Institute for Chemical Biology and the Lita Annenberg Hazen Foundation.


Story Source:

The above story is based on materials provided by Scripps Research Institute. Note: Materials may be edited for content and length.


Cite This Page:

Scripps Research Institute. "Scientists At The Scripps Research Institute Discover A Therapeutic Strategy For "Misfolding Diseases" Analogous To Alzheimer's Disease." ScienceDaily. ScienceDaily, 4 October 2001. <www.sciencedaily.com/releases/2001/10/011003064151.htm>.
Scripps Research Institute. (2001, October 4). Scientists At The Scripps Research Institute Discover A Therapeutic Strategy For "Misfolding Diseases" Analogous To Alzheimer's Disease. ScienceDaily. Retrieved April 1, 2015 from www.sciencedaily.com/releases/2001/10/011003064151.htm
Scripps Research Institute. "Scientists At The Scripps Research Institute Discover A Therapeutic Strategy For "Misfolding Diseases" Analogous To Alzheimer's Disease." ScienceDaily. www.sciencedaily.com/releases/2001/10/011003064151.htm (accessed April 1, 2015).

Share This


More From ScienceDaily



More Mind & Brain News

Wednesday, April 1, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

AAA: Distracted Driving a Serious Teen Problem

AAA: Distracted Driving a Serious Teen Problem

AP (Mar. 25, 2015) — While distracted driving is not a new problem for teens, new research from the AAA Foundation for Traffic Safety says it&apos;s much more serious than previously thought. (March 25) Video provided by AP
Powered by NewsLook.com
Smartphone Use Changing Our Brain and Thumb Interaction, Say Researchers

Smartphone Use Changing Our Brain and Thumb Interaction, Say Researchers

Reuters - Innovations Video Online (Mar. 25, 2015) — European researchers say our smartphone use offers scientists an ideal testing ground for human brain plasticity. Dr Ako Ghosh&apos;s team discovered that the brains and thumbs of smartphone users interact differently from those who use old-fashioned handsets. Jim Drury went to meet him. Video provided by Reuters
Powered by NewsLook.com
Many Don't Know They Have Alzheimer's, But Their Doctors Do

Many Don't Know They Have Alzheimer's, But Their Doctors Do

Newsy (Mar. 24, 2015) — According to a new study by the Alzheimer&apos;s Association, more than half of those who have the degenerative brain disease aren&apos;t told by their doctors. Video provided by Newsy
Powered by NewsLook.com
A Quick 45-Minute Nap Can Improve Your Memory

A Quick 45-Minute Nap Can Improve Your Memory

Newsy (Mar. 23, 2015) — Researchers found those who napped for 45 minutes to an hour before being tested on information recalled it five times better than those who didn&apos;t. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins